<DOC>
	<DOCNO>NCT00533390</DOCNO>
	<brief_summary>Rifampicin potent inducer CYP450 decrease plasmatic concentration NNRTI Protease Inhibitors . In study go compare 600 800mg dos efavirenz concomitant rifampicin use treat tuberculosis . The hypothesis 800 mg dose would adequate 600mg</brief_summary>
	<brief_title>Randomized Clinical Trial Assess Efficacy Safety Concomitant Use Rifampicin Efavirenz 600 X 800mg</brief_title>
	<detailed_description>The study consist open label randomize clinical trial compare efavirenz 600mg QID versus efavirenz 800mg QID patient tuberculosis ( treated regimen include rifampicin ) AIDS diagnosis . The total duration study 6 month patient . All eligible patient treat fist line regimen tuberculosis accord Brazilian guideline : rifampicin ( 600mg QID ) ; isoniazid ( 400mg QID ) e pyrazinamide ( 2g QID ) 6 month weight 45 kg adapt dos person le 45 kg . For patient previous history TB therapy etambutol 1.200mg QID add regimen . Both group receive nucleoside reverse transcriptase inhibitor ( NRTI ) non nucleoside transcriptase inhibitor ( NNRTI ) treat HIV . The ITRN first choice zidovudine lamivudine association . Patients present contra indication use drug receive others NRTI . The NNRTI efavirenz ( 800 600mg ) . Antiretrovirals initiate 30 day stable TB therapy . In case adverse event TB therapy lead treatment interruption , study drug delay 30th day triple therapy TB . During HIV therapy NRTI change case intolerance</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Adults tuberculosis diagnosis , HIV positive . Agreement avoid allow drug trial , agreement participate study ( informed consent ) Active liver disease Pregnancy breast feed CD4 count &gt; 350</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>efavirenz</keyword>
	<keyword>tuberculosis</keyword>
	<keyword>AIDS</keyword>
	<keyword>rifampicin</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>